Report on Carcinogens Webinar on Pentachlorophenol; Notice of Public Webinar and Registration Information, 15020 [2013-05405]
Download as PDF
15020
Federal Register / Vol. 78, No. 46 / Friday, March 8, 2013 / Notices
Dated: March 5, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–05471 Filed 3–7–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Report on Carcinogens Webinar on
Pentachlorophenol; Notice of Public
Webinar and Registration Information
SUMMARY: The National Toxicology
Program (NTP) announces a public
webinar, ‘‘Human cancer studies on
exposure to pentachlorophenol (PCP):
Differentiating potential cancer effects
of PCP exposure from effects due to
occupational co-exposures or PCP
contaminants.’’ The Office of the Report
on Carcinogens (ORoC), Division of the
NTP (DNTP), National Institute of
Environmental Health Sciences (NIEHS)
will hold the webinar using Adobe®
ConnectTM, and the public can register
to attend.
DATES:
Webinar: April 11, 2013, 12:30 p.m. to
approximately 5:00 p.m. Eastern
Daylight Time (EDT).
Pre-Registration for Webinar: March 8,
2013 to April 8, 2013.
ADDRESSES:
Webinar Web page: The agenda,
speaker abstracts, registration, and other
meeting materials are at https://
ntp.niehs.nih.gov/go/pcpwebinar.
FOR FURTHER INFORMATION CONTACT: Dr.
Ruth M. Lunn, Director, ORoC, DNTP,
NIEHS, P.O. Box 12233, MD K2–14,
Research Triangle Park, NC 27709.
Phone: (919) 316–4637; Fax: (301) 480–
2970, Email: lunn@niehs.nih.gov. Hand
Delivery/Courier: 530 Davis Drive,
Room 2138, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: The Report on
Carcinogens (RoC) is a congressionally
mandated, science-based, public health
report that identifies agents, substances,
mixtures, or exposures (collectively
called ‘‘substances’’) in our environment
that are cancer hazards for people living
in the United States. The NTP prepares
the RoC on behalf of the Secretary of
Health and Human Services following
an established, four-part process
(https://ntp.niehs.nih.gov/go/rocprocess).
PCP, including its sodium salt, is a
chlorinated aromatic compound that is
used primarily as a wood preservative
in the United States. It was selected as
a candidate substance following
solicitation of public comment and
review by the NTP Board of Scientific
VerDate Mar<15>2010
18:44 Mar 07, 2013
Jkt 229001
Counselors on June 21–22, 2012
(https://ntp.niehs.nih.gov/go/9741) (for
more information on the status of NTP
review of PCP see https://
ntp.niehs.nih.gov/go/37897).
The objective of the webinar is to
provide scientific input to the ORoC on
issues related to its approach for
evaluating the epidemiologic studies on
exposure to PCP and not to receive
recommendations from invited speakers
or the public on whether or not PCP
should be listed in the RoC. The
webinar will consist of (1) four
presentations, each of which will be
followed by a short question and answer
period specific for the presentation, and
(2) a discussion session across
presentations. The goals of the
individual presentations are (1) to
identify occupational co-exposures and
PCP components or contaminants in
human epidemiologic studies of
exposure to PCP, (2) to identify which
co-exposures should be considered as
potential confounders, and (3) to
discuss the methods used in the
epidemiologic studies to evaluate
confounding.
Webinar and Registration: The
webinar is scheduled for April 11, 2013,
from 12:30 to approximately 5 p.m.
e.d.t. The webinar may end early if the
presentations and general discussion
period are finished. The public may
register for the webinar beginning
March 8, 2013, through April 8, 2013, at
https://ntp.niehs.nih.gov/go/pcpwebinar.
There will be 50 connections available
on a first-come, first-served basis for
registrants. Registrants will receive
instructions by email to access the
webinar (via Adobe® ConnectTM) on or
before April 9, 2013.
The preliminary agenda, list of
speakers, and abstracts of the
presentations should be posted on the
NTP Web site (https://ntp.niehs.nih.gov/
go/pcpwebinar) by March 26, 2013.
Registrants are encouraged to access the
webinar Web page to stay abreast of the
most current information regarding this
event. Any updates will be posted to the
Web site.
Public Participation: Time will be set
aside following each presentation and
during the general discussion period
after the talks are finished for the public
to ask questions or make brief remarks.
Instructions for participating in the
meeting via Adobe® ConnectTM will be
included in the information for
accessing the webinar. Individuals with
disabilities who need accommodation to
participate in this event should contact
Dr. Lunn. TTY users should contact the
Federal TTY Relay Service at 800–877–
8339. Requests should be made at least
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
five business days in advance of the
event.
Background Information on the RoC:
Published biennially, each edition of the
RoC is cumulative and consists of
substances newly reviewed in addition
to those listed in previous editions. The
12th RoC, the latest edition, was
published on June 10, 2011 (available at
https://ntp.niehs.nih.gov/go/roc12). The
13th RoC is under development. For
each listed substance, the RoC contains
a substance profile, which provides
information on: Cancer studies that
support the listing—including those in
humans, animals, and studies on
possible mechanisms of action—
information about potential sources of
exposure to humans, and current
Federal regulations to limit exposures.
Dated: March 4, 2013.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2013–05405 Filed 3–7–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review K99 Grant Applications.
Date: April 3, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: John J. Laffan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.18J, Bethesda, MD
20892, 301–594–2773, laffanjo@mail.nih.gov.
E:\FR\FM\08MRN1.SGM
08MRN1
Agencies
[Federal Register Volume 78, Number 46 (Friday, March 8, 2013)]
[Notices]
[Page 15020]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05405]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Report on Carcinogens Webinar on Pentachlorophenol; Notice of
Public Webinar and Registration Information
SUMMARY: The National Toxicology Program (NTP) announces a public
webinar, ``Human cancer studies on exposure to pentachlorophenol (PCP):
Differentiating potential cancer effects of PCP exposure from effects
due to occupational co-exposures or PCP contaminants.'' The Office of
the Report on Carcinogens (ORoC), Division of the NTP (DNTP), National
Institute of Environmental Health Sciences (NIEHS) will hold the
webinar using Adobe[supreg] ConnectTM, and the public can
register to attend.
DATES:
Webinar: April 11, 2013, 12:30 p.m. to approximately 5:00 p.m.
Eastern Daylight Time (EDT).
Pre-Registration for Webinar: March 8, 2013 to April 8, 2013.
ADDRESSES:
Webinar Web page: The agenda, speaker abstracts, registration, and
other meeting materials are at https://ntp.niehs.nih.gov/go/pcpwebinar.
FOR FURTHER INFORMATION CONTACT: Dr. Ruth M. Lunn, Director, ORoC,
DNTP, NIEHS, P.O. Box 12233, MD K2-14, Research Triangle Park, NC
27709. Phone: (919) 316-4637; Fax: (301) 480-2970, Email:
lunn@niehs.nih.gov. Hand Delivery/Courier: 530 Davis Drive, Room 2138,
Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: The Report on Carcinogens (RoC) is a congressionally
mandated, science-based, public health report that identifies agents,
substances, mixtures, or exposures (collectively called ``substances'')
in our environment that are cancer hazards for people living in the
United States. The NTP prepares the RoC on behalf of the Secretary of
Health and Human Services following an established, four-part process
(https://ntp.niehs.nih.gov/go/rocprocess).
PCP, including its sodium salt, is a chlorinated aromatic compound
that is used primarily as a wood preservative in the United States. It
was selected as a candidate substance following solicitation of public
comment and review by the NTP Board of Scientific Counselors on June
21-22, 2012 (https://ntp.niehs.nih.gov/go/9741) (for more information on
the status of NTP review of PCP see https://ntp.niehs.nih.gov/go/37897).
The objective of the webinar is to provide scientific input to the
ORoC on issues related to its approach for evaluating the epidemiologic
studies on exposure to PCP and not to receive recommendations from
invited speakers or the public on whether or not PCP should be listed
in the RoC. The webinar will consist of (1) four presentations, each of
which will be followed by a short question and answer period specific
for the presentation, and (2) a discussion session across
presentations. The goals of the individual presentations are (1) to
identify occupational co-exposures and PCP components or contaminants
in human epidemiologic studies of exposure to PCP, (2) to identify
which co-exposures should be considered as potential confounders, and
(3) to discuss the methods used in the epidemiologic studies to
evaluate confounding.
Webinar and Registration: The webinar is scheduled for April 11,
2013, from 12:30 to approximately 5 p.m. e.d.t. The webinar may end
early if the presentations and general discussion period are finished.
The public may register for the webinar beginning March 8, 2013,
through April 8, 2013, at https://ntp.niehs.nih.gov/go/pcpwebinar. There
will be 50 connections available on a first-come, first-served basis
for registrants. Registrants will receive instructions by email to
access the webinar (via Adobe[supreg] Connect\TM\) on or before April
9, 2013.
The preliminary agenda, list of speakers, and abstracts of the
presentations should be posted on the NTP Web site (https://ntp.niehs.nih.gov/go/pcpwebinar) by March 26, 2013. Registrants are
encouraged to access the webinar Web page to stay abreast of the most
current information regarding this event. Any updates will be posted to
the Web site.
Public Participation: Time will be set aside following each
presentation and during the general discussion period after the talks
are finished for the public to ask questions or make brief remarks.
Instructions for participating in the meeting via Adobe[supreg]
Connect\TM\ will be included in the information for accessing the
webinar. Individuals with disabilities who need accommodation to
participate in this event should contact Dr. Lunn. TTY users should
contact the Federal TTY Relay Service at 800-877-8339. Requests should
be made at least five business days in advance of the event.
Background Information on the RoC: Published biennially, each
edition of the RoC is cumulative and consists of substances newly
reviewed in addition to those listed in previous editions. The 12th
RoC, the latest edition, was published on June 10, 2011 (available at
https://ntp.niehs.nih.gov/go/roc12). The 13th RoC is under development.
For each listed substance, the RoC contains a substance profile, which
provides information on: Cancer studies that support the listing--
including those in humans, animals, and studies on possible mechanisms
of action--information about potential sources of exposure to humans,
and current Federal regulations to limit exposures.
Dated: March 4, 2013.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2013-05405 Filed 3-7-13; 8:45 am]
BILLING CODE 4140-01-P